CompletedPhase 1/2

Analyzing the Composition of Tears to Identify Cancer

United States150 participantsStarted 2006-12

Plain-language summary

This study will further evaluate the use of protein identification or protein pattern (signature) found in tears. We hypothesize that differences exist between the protein profile in tear fluid from patients with versus without cancer.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Female or male, 18-100 years old * Patients who present for a routine check-up * Patients who present for the evaluation of an abnormal exam or test (mammogram, ultrasound, MRI, PET, etc.) * May or may not have a mass present * Patients who present for the evaluation of a palpable lump or mass * Patients may be pre or post biopsy for a mass, as long as there is a portion of the mass remaining Exclusion Criteria: * Patient \< 18 y/o or \> 100 y/o * Concurrent eye infection or trauma * Active conjunctivitis * Abnormal production of tears (too much or too little)

What they're measuring

This study will further evaluate the use of tumor markers (substances in body fluids that may be elevated as a consequence of certain diseases or conditions) in the diagnosis of breast and/or other cancers.

Timeframe: Collection of specimen and analysis with SELDI-MS

Trial details

NCT IDNCT00574678

SponsorUniversity of Arkansas

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2016-02

View on ClinicalTrials.gov More Breast Cancer trials